Chronic hepatitis B virus infection

WK Seto, YR Lo, JM Pawlotsky, MF Yuen - The Lancet, 2018 - thelancet.com
Chronic hepatitis B virus infection is a global public health threat that causes considerable
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …

Chronic hepatitis B infection: a review

LSY Tang, E Covert, E Wilson, S Kottilil - Jama, 2018 - jamanetwork.com
Importance More than 240 million individuals worldwide are infected with chronic hepatitis B
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …

[PDF][PDF] A ASLD guidelines for treatment of chronic hepatitis B

NA Terrault, NH Bzowej, KM Chang, JP Hwang… - …, 2016 - Wiley Online Library
A<fc>ASLD</fc> guidelines for treatment of chronic hepatitis <fc>B</fc> Page 1 PRACTICE
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …

Getting to HBV cure: The promising paths forward

S Fung, HSJ Choi, A Gehring, HLA Janssen - Hepatology, 2022 - Wiley Online Library
Chronic HBV infection is a global public health burden estimated to impact nearly 300
million persons worldwide. Despite the advent of potent antiviral agents that effectively …

Hepatitis B virus infection

C Trépo, HLY Chan, A Lok - The Lancet, 2014 - thelancet.com
Hepatitis B virus infection is a major public health problem worldwide; roughly 30% of the
world's population show serological evidence of current or past infection. Hepatitis B virus is …

[HTML][HTML] Current trend in antiviral therapy for chronic hepatitis B

RN Chien, YF Liaw - Viruses, 2022 - mdpi.com
Since active hepatitis B virus (HBV) replication is the key driver of hepatic necroinflammation
and disease progression, the treatment aim of chronic hepatitis B (CHB) is to suppress HBV …

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos (t) ide analogues

TCF Yip, GLH Wong, HLY Chan, YK Tse, KLY Lam… - Journal of …, 2019 - Elsevier
Background & Aims In treated patients with chronic hepatitis B (CHB) who have achieved
complete viral suppression, it is unclear if functional cure as indicated by hepatitis B surface …

[HTML][HTML] EASL clinical practice guidelines: management of chronic hepatitis B virus infection

European Association For The Study Of The Liver - Journal of hepatology, 2012 - Elsevier
Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug …

RP Perrillo, R Gish, YT Falck-Ytter - Gastroenterology, 2015 - gastrojournal.org
This article has an accompanying continuing medical education activity on page e16.
Learning Objective: Upon completion of the CME activity, successful learners will be able to …

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B

GA Kim, YS Lim, S Han, J Choi, JH Shim, KM Kim… - Gut, 2018 - gut.bmj.com
Objective High serum HBV DNA levels are associated with high risks of hepatocellular
carcinoma (HCC) and cirrhosis in patients with chronic hepatitis B (CHB). Although the …